Bavarian Nordic AS (CHIX:BAVAC) Debt-to-Asset : 0.01 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:BAVAC Bavarian Nordic AS CHIX:BAVAC
77 GF Score
Price kr216.80
GF Value kr176.53
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bavarian Nordic AS Debt-to-Asset?

Bavarian Nordic AS CHIX:BAVAC 77 Debt-to-Asset is 0.01 as of Jun. 2026. GuruFocus rates CHIX:BAVAC with a GF Score™ of 77/100 and a GF Value™ of kr176.53 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Bavarian Nordic AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was kr46 Mil. Bavarian Nordic AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was kr85 Mil. Bavarian Nordic AS's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2026 was kr14,723 Mil. Bavarian Nordic AS's debt to asset for the quarter that ended in Jun. 2026 was 0.01.

Bavarian Nordic AS  (CHIX:BAVAc) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Bavarian Nordic AS Debt-to-Asset Related Terms

Bavarian Nordic AS Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Bavarian Nordic AS's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic AS Debt-to-Asset Chart

Bavarian Nordic AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.14 0.01 0.01 0.01

Bavarian Nordic AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

CHIX:BAVAC vs VRTX, REGN, RVMD: Debt-to-Asset Comparison

For the Biotechnology subindustry, Bavarian Nordic AS's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bavarian Nordic AS Debt-to-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic AS's Debt-to-Asset falls into.


CHIX:BAVAC
77GF Score
Bavarian Nordic AS CHIX:BAVAC
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bavarian Nordic AS Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Bavarian Nordic AS's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(45.518 + 85.352) / 14954.537
=0.01

Bavarian Nordic AS's Debt-to-Asset for the quarter that ended in Jun. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(45.931 + 85.408) / 14722.762
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.01 mean?
Bavarian Nordic AS (CHIX:BAVAC) has a Debt-to-Asset of 0.01 as of Jun. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Bavarian Nordic AS and its competitors.
Is Bavarian Nordic AS's Debt-to-Asset too high?
Bavarian Nordic AS's current Debt-to-Asset is 0.01. Overall, Bavarian Nordic AS has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's Debt-to-Asset compare to VRTX and REGN?
Bavarian Nordic AS's Debt-to-Asset of 0.01 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Biotechnology company?
A good Debt-to-Asset depends on the Biotechnology industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Bavarian Nordic AS and its competitors. Bavarian Nordic AS's current Debt-to-Asset is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Based on GuruFocus' analysis, Bavarian Nordic AS (CHIX:BAVAC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr176.53, compared to a current price of kr216.80 — trading 22.8% above its estimated fair value. The current Debt-to-Asset is 0.01. Bavarian Nordic AS's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Bavarian Nordic AS (CHIX:BAVAC), the current Debt-to-Asset is 0.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bavarian Nordic AS (CHIX:BAVAC) Overvalued in 2026?

Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued. The current stock price of kr216.80 is trading 22.8% above its estimated GF Value™ of kr176.53. GuruFocus considers Bavarian Nordic AS to be Modestly Overvalued.

Key valuation signals for CHIX:BAVAC:

  • Debt-to-Asset: 0.01
  • GF Value™: kr176.53 vs. price of kr216.80 (22.8% above fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the CHIX:BAVAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bavarian Nordic AS Business Description

Address Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
77GF Score

Get the complete analysis for CHIX:BAVAC

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr216.80
Price
kr176.53
GF Value